Posts tagged “Biotech & Life Science”
David Levin, the veteran Triangle entrepreneur who is CEO of analytics startup Bivarus, talks about what's next for the company which recently raised venture funding, made an acquisition in Hickory, and has big plans for the future. Plus. Bivarus is hiring. He also explains why Bivarus bought Jackson Group - in part for something called CAHPS.
Durham-based life science services giant Quintiles is merging with IMS Health Holdings in a deal forming a company worth some $17.6 billion. The merger was announced early Tuesday. Quintiles founder Dennis Gillings will lead the combined board but IMS shareholders will hold majority of stock. Wall Street, however, reacts negatively to the news.
The merger of Quintiles and IMS Health creating a $17 billion health services company announced Tuesday can be traced back to a meeting between the two CEOs last year. Quintiles' Tom Pike tells analysts the two firms discovered quickly how well they could work together, and the CEO of IMS says the collaboration has already delivered "major wins."
Tuesday's merger of Quintiles with IMS Health Services might trigger other CRO deals affecting the Triangle, says Chapel Hill-based analyst Andrew Schafer of Industry Standard Research. Also, Wall Street is giving the Q deal the thumbs down as shares tumble 8 percent. Why? Schafer explains. Plus, a Bloomberg columnist weighs in.
Bivarus, a startup focusing on patient experience anayltics that raised $2 million in March, has acquired a Hickory-based firm that provides healthcare measurement and consulting.
Any time companies merger, they talk about cost savings and "synergies." That often means layoffs with redundant services and more often being cut. So will there be an immediate impact in Durham at Quintiles' global headquarters? And why merge with IMS Health Services? WTW asks a Quintiles exec for details.
INC Research's latest earnings report reflects growth in earnings, revenue and hiring. But a separate SEC filing discloses 175 layoffs as part of a reorganization. More are coming. Company execs also say they are using more contractors, which often are more expensive than full-time employees. What's going on? CROs such as INC, and Quintiles are battling for a particular kind of talent. They are known as CRAs.
BASF says its layoffs in Research Triangle Park are expected to affect "only 106 jobs," not as many as 190 as cited in a mass layoff filing with the state of North Carolina.
In today's Bulldog wrapup of technology and life science news: The search resumes for the "God particle" at CERN; the FDA approves a Parkinson's disease drug; Marissa Mayer gets $55 million severance package if ousted; and billionaire Carl Icahn sells his stake in Apple.
WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.
Bob Ingram, a longtime Triangle pharmaceutical executive and investor, has been renominated to the board of directors at troubled Valeant Pharmaceuticals. He will be replaced as chairman by incoming CEO Joe Papa.
RTP headlines: AgBiome opens new facility; NC leads in grid storage; PRA beats Street; MaxPoint reverse split
In our latest wrapup of Triangle headlines: AgBiome moves into new headquarters in RTP; a North Carolina utility takes the lead in power grid storage; PRA Health Sciences earnings tops analysts expectations; and MaxPoint pulls off a reverse merger.
Practichem, a biotechnology instrumentation and software startup based in Raleigh, is a company you may not have heard much about. Until Thursday. Landing $5 million in funding is generating buzz. In an exclusive Q&A, its founder and CEO talks about plans for the funding, hiring, sales, new products, and the benefits of moving to Raleigh from Wisconsin.
One of the most significant incubators of small businesses in North Carolina is celebrating National Small Business Week with a visit from its district's Congressman -- and hopefully, from you. Plus, there will be pitches by startups hoping to attract interest from investors.
In today's Bulldog wrapup of technology and life science news: Apple unveils medical apps for iPhones; Sanofi badly wants to buy a San Francisco pharmaceutical firm; Comcast is buying DreamWorks; and the FTC wins court case over in-apps purchases made by children through Amazon.
Practichem, a biotechnology instrumentation and software startup based in Raleigh, raises $5 million from investors. The company plans to expand its staff in multiple areas as a result.
Valeant, which acquired two Raleigh-based drug firms last year, is blasted for its pricing strategies in a U.S. Senate hearing on Wednesday. Meanwhile, The Wall Street Journal reports that veteran Triangle life science executive Bob Ingram is going to give up his post as board chairman.
A group of states including North Carolina settled with drug maker Pfizer on Wednesday to settle two lawsuits that alleged the company owed millions in rebates to Medicaid for heartburn and acid reflux medications.